“cystic-fibrosis” Archives

in
Entry Author Date Location
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential 02/12/20 San Diego
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Vertex Stock Up on Quick FDA OK For 3-Drug Cystic Fibrosis Therapy 10/22/19 Boston
Vertex Bets $950M on Semma and a Stem Cell Therapy for Diabetes 09/03/19 Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles 07/25/19 Boston
Vertex Pharma Shells Out $420M to Move Into Muscular Dystrophy 06/07/19 Boston
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Vertex Selects Drug Combo, a Potential Therapy for 90% of CF Patients 05/30/19 Boston
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera 05/15/19 Boston
Analysts: Proteostasis Data Are No Boost vs. Vertex in Cystic Fibrosis 03/25/19 Boston
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3 03/06/19 Boston
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
Vertex Hums Along as AbbVie Snatches Up a Rival’s CF Drugs for $45M 10/25/18 Boston
Tvardi, Co-Founded by Former MD Anderson Leader DePinho, Raises $9M 09/27/18 Texas
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bio Roundup: Wrapping ASCO, Dreaming IPO, Rebooting Axovant & More 06/08/18 National
Vertex CF Competitor Proteostasis Falters, Galapagos Up Next 06/07/18 Boston
FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study 05/30/18 Boston
Moving Beyond Obesity, Vivus Strikes $135M Deal for Digestive Drug 05/01/18 San Francisco
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
Bio Roundup: Trump’s Budget, Biogen’s AD Reveal, Hugin’s Run & More 02/16/18 National
Page 1 of 7 next page »